Additional information
White Powder
324561-87-7
ACI-030912
46.7-47.7°C
C11H9F3O2
230.18
Ambient
2-8°C
Anti-inflammatory
Pharmaceutical Impurity Standards
1,1,1-Trifluoro-4-hydroxy-4-(4-methylphenyl)-3-buten-2-one
1,1,1-Trifluoro-4-hydroxy-4-(4-methylphenyl)-3-buten-2-one
2-Buten-1-one, 4,4,4-trifluoro-3-hydroxy-1-(4-methylphenyl)





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)